Influence of dose and schedule on the therapeutic efficacy of 131I-labelled monoclonal antibody 139H2 in a human ovarian cancer xenograft model

C.F.M. Molthoff; H.M. Pinedo; M.M. Schlüper; E. Boven

Influence of dose and schedule on the therapeutic efficacy of 131I-labelled monoclonal antibody 139H2 in a human ovarian cancer xenograft model

C.F.M. Molthoff, H.M. Pinedo, M.M. Schlüper, E. Boven

VU University medical center

Research output: Contribution to journal › Article › Academic › peer-review

6 Downloads (Pure)

Original language	English
Pages (from-to)	474-480
Journal	International Journal of Cancer
Volume	50
Publication status	Published - 1992

Access to Document

8443Final published version, 7 MB

Cite this

@article{8f829b409a714ae2aeb17c5bd37b647c,

title = "Influence of dose and schedule on the therapeutic efficacy of 131I-labelled monoclonal antibody 139H2 in a human ovarian cancer xenograft model",

author = "C.F.M. Molthoff and H.M. Pinedo and M.M. Schl{\"u}per and E. Boven",

year = "1992",

language = "English",

volume = "50",

pages = "474--480",

journal = "International Journal of Cancer",

issn = "0020-7136",

publisher = "Wiley-Liss Inc.",

}

TY - JOUR

T1 - Influence of dose and schedule on the therapeutic efficacy of 131I-labelled monoclonal antibody 139H2 in a human ovarian cancer xenograft model

AU - Molthoff, C.F.M.

AU - Pinedo, H.M.

AU - Schlüper, M.M.

AU - Boven, E.

PY - 1992

Y1 - 1992

M3 - Article

VL - 50

SP - 474

EP - 480

JO - International Journal of Cancer

JF - International Journal of Cancer

SN - 0020-7136

ER -